TY  - GEN
AU  - Takeuchi,Ario
AU  - Eto,Masatoshi
AU  - Shiota,Masaki
AU  - Tatsugami,Katsunori
AU  - Yokomizo,Akira
AU  - Kuroiwa,Kentaro
AU  - Itsumi,Momoe
AU  - Naito,Seiji
TI  - Sunitinib enhances antitumor effects against chemotherapy-resistant             bladder cancer through suppression of ERK1/2 phosphorylation
SN  - 1791-2423
PY  - 2012///0629
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Blotting, Western
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Dose-Response Relationship, Drug
KW  - Down-Regulation
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Mice
KW  - Mice, Inbred C3H
KW  - Mice, Nude
KW  - Mitogen-Activated Protein Kinase 1
KW  - antagonists & inhibitors
KW  - Mitogen-Activated Protein Kinase 3
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Pyrroles
KW  - Signal Transduction
KW  - Sunitinib
KW  - T-Lymphocytes, Cytotoxic
KW  - T-Lymphocytes, Regulatory
KW  - Time Factors
KW  - Tumor Burden
KW  - Urinary Bladder Neoplasms
KW  - drug therapy
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3892/ijo.2012.1368
ER  -